Abstract
Autism spectrum disorders (ASD) encompass a range of neurodevelopmental conditions that are clinically and etiologically very heterogeneous. ASD is currently diagnosed entirely on behavioral criteria, but intensive research efforts are focused on identifying biological markers for disease risk and early diagnosis. Here, we discuss recent progress toward identifying biological markers for ASD and highlight specific challenges as well as ethical aspects of translating ASD biomarker research into the clinic.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Animals
-
Brain / pathology
-
Brain / physiopathology
-
Cephalometry
-
Child Development Disorders, Pervasive / diagnosis
-
Child Development Disorders, Pervasive / genetics
-
Child Development Disorders, Pervasive / immunology
-
Child Development Disorders, Pervasive / metabolism*
-
Genetic Markers
-
Genetic Predisposition to Disease
-
Humans
-
Mitochondria / metabolism
-
Oxidative Stress
-
Serotonin / metabolism
-
Transcriptome
Substances
-
Genetic Markers
-
Serotonin